Oxford Immunotec Global Plc (OXFD) SEC Filing 8-K Material Event for the period ending Tuesday, March 5, 2019

Oxford Immunotec Global Plc

CIK: 1586049 Ticker: OXFD

View differences made from one to another to evaluate Oxford Immunotec Global Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Oxford Immunotec Global Plc.


Assess how Oxford Immunotec Global Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Oxford Immunotec Global Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: OXFD
CIK: 1586049
Form Type: 8-K Corporate News
Accession Number: 0001437749-19-004471
Submitted to the SEC: Fri Mar 08 2019 4:30:53 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Tuesday, March 5, 2019
Industry: In Vitro And In Vivo Diagnostic Substances
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: